scPharmaceuticals Inc (SCPH)
4.07
+0.04
(+0.99%)
USD |
NASDAQ |
Nov 05, 11:17
scPharmaceuticals Price to Book Value: 22.01 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 21.80 |
| November 01, 2024 | 22.01 |
| October 31, 2024 | 22.45 |
| October 30, 2024 | 24.12 |
| October 29, 2024 | 23.96 |
| October 28, 2024 | 23.64 |
| October 25, 2024 | 22.72 |
| October 24, 2024 | 22.61 |
| October 23, 2024 | 23.64 |
| October 22, 2024 | 23.85 |
| October 21, 2024 | 23.91 |
| October 18, 2024 | 24.50 |
| October 17, 2024 | 23.74 |
| October 16, 2024 | 23.85 |
| October 15, 2024 | 23.04 |
| October 14, 2024 | 22.72 |
| October 11, 2024 | 22.88 |
| October 10, 2024 | 22.07 |
| October 09, 2024 | 21.31 |
| October 08, 2024 | 21.50 |
| October 07, 2024 | 22.01 |
| October 04, 2024 | 23.15 |
| October 03, 2024 | 23.47 |
| October 02, 2024 | 23.58 |
| October 01, 2024 | 22.77 |
| Date | Value |
|---|---|
| September 30, 2024 | 24.66 |
| September 27, 2024 | 24.93 |
| September 26, 2024 | 23.91 |
| September 25, 2024 | 25.10 |
| September 24, 2024 | 25.80 |
| September 23, 2024 | 26.02 |
| September 20, 2024 | 28.02 |
| September 19, 2024 | 28.45 |
| September 18, 2024 | 29.37 |
| September 17, 2024 | 29.80 |
| September 16, 2024 | 29.80 |
| September 13, 2024 | 29.69 |
| September 12, 2024 | 28.72 |
| September 11, 2024 | 27.64 |
| September 10, 2024 | 27.04 |
| September 09, 2024 | 27.31 |
| September 06, 2024 | 27.64 |
| September 05, 2024 | 28.07 |
| September 04, 2024 | 27.53 |
| September 03, 2024 | 26.77 |
| August 30, 2024 | 27.53 |
| August 29, 2024 | 27.26 |
| August 28, 2024 | 26.61 |
| August 27, 2024 | 27.85 |
| August 26, 2024 | 28.18 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.320
Minimum
Dec 11 2019
29.80
Maximum
Sep 16 2024
4.871
Average
3.266
Median
Feb 14 2020
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.096 |
| Theriva Biologics Inc | 0.0784 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 6.579 |
| Price | 4.07 |
| Earnings Yield | -38.33% |
| Market Cap | 203.62M |